%PDF- %PDF-
Mini Shell

Mini Shell

Direktori : /var/www/html/digiprint/public/site/tnuujq/cache/
Upload File :
Create Path :
Current File : /var/www/html/digiprint/public/site/tnuujq/cache/d8e86367a51461e9bccb1bedac5bf5e5

a:5:{s:8:"template";s:9437:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Open+Sans%3A300%2C400%2C600%2C700%2C800%7CRoboto%3A100%2C300%2C400%2C500%2C600%2C700%2C900%7CRaleway%3A600%7Citalic&amp;subset=latin%2Clatin-ext" id="quality-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css"> html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background:0 0}a:active,a:hover{outline:0}@media print{*{color:#000!important;text-shadow:none!important;background:0 0!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}p{orphans:3;widows:3}.navbar{display:none}}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:62.5%;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#428bca;text-decoration:none}a:focus,a:hover{color:#2a6496;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}ul{margin-top:0;margin-bottom:10px}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-md-12{position:relative;min-height:1px;padding-right:15px;padding-left:15px}@media (min-width:992px){.col-md-12{float:left}.col-md-12{width:100%}}.collapse{display:none} .nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{max-height:340px;padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:0;margin-left:0}}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}.navbar-nav.navbar-right:last-child{margin-right:-15px}}@media (min-width:768px){.navbar-right{float:right!important}}.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{display:table;content:" "}.clearfix:after,.container-fluid:after,.container:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}html{font-size:14px;overflow-y:scroll;overflow-x:hidden;-ms-overflow-style:scrollbar}@media(min-width:60em){html{font-size:16px}}body{background:#fff;color:#6a6a6a;font-family:"Open Sans",Helvetica,Arial,sans-serif;font-size:1rem;line-height:1.5;font-weight:400;padding:0;background-attachment:fixed;text-rendering:optimizeLegibility;overflow-x:hidden;transition:.5s ease all}p{line-height:1.7;margin:0 0 25px}p:last-child{margin:0}a{transition:all .3s ease 0s}a:focus,a:hover{color:#121212;outline:0;text-decoration:none}.padding-0{padding-left:0;padding-right:0}ul{font-weight:400;margin:0 0 25px 0;padding-left:18px}ul{list-style:disc}ul>li{margin:0;padding:.5rem 0;border:none}ul li:last-child{padding-bottom:0}.site-footer{background-color:#1a1a1a;margin:0;padding:0;width:100%;font-size:.938rem}.site-info{border-top:1px solid rgba(255,255,255,.1);padding:30px 0;text-align:center}.site-info p{color:#adadad;margin:0;padding:0}.navbar-custom .navbar-brand{padding:25px 10px 16px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{color:#f8504b}a{color:#f8504b}.navbar-custom{background-color:transparent;border:0;border-radius:0;z-index:1000;font-size:1rem;transition:background,padding .4s ease-in-out 0s;margin:0;min-height:100px}.navbar a{transition:color 125ms ease-in-out 0s}.navbar-custom .navbar-brand{letter-spacing:1px;font-weight:600;font-size:2rem;line-height:1.5;color:#121213;margin-left:0!important;height:auto;padding:26px 30px 26px 15px}@media (min-width:768px){.navbar-custom .navbar-brand{padding:26px 10px 26px 0}}.navbar-custom .navbar-nav li{margin:0 10px;padding:0}.navbar-custom .navbar-nav li>a{position:relative;color:#121213;font-weight:600;font-size:1rem;line-height:1.4;padding:40px 15px 40px 15px;transition:all .35s ease}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0}@media (max-width:991px){.navbar-custom .navbar-nav{letter-spacing:0;margin-top:1px}.navbar-custom .navbar-nav li{margin:0 20px;padding:0}.navbar-custom .navbar-nav li>a{color:#bbb;padding:12px 0 12px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0;color:#fff}.navbar-custom li a{border-bottom:1px solid rgba(73,71,71,.3)!important}.navbar-header{float:none}.navbar-collapse{border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.collapse{display:none!important}.navbar-custom .navbar-nav{background-color:#1a1a1a;float:none!important;margin:0!important}.navbar-custom .navbar-nav>li{float:none}.navbar-header{padding:0 130px}.navbar-collapse{padding-right:0;padding-left:0}}@media (max-width:768px){.navbar-header{padding:0 15px}.navbar-collapse{padding-right:15px;padding-left:15px}}@media (max-width:500px){.navbar-custom .navbar-brand{float:none;display:block;text-align:center;padding:25px 15px 12px 15px}}@media (min-width:992px){.navbar-custom .container-fluid{width:970px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}}@media (min-width:1200px){.navbar-custom .container-fluid{width:1170px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}} @font-face{font-family:'Open Sans';font-style:normal;font-weight:300;src:local('Open Sans Light'),local('OpenSans-Light'),url(http://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN_r8OXOhs.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(http://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFW50e.ttf) format('truetype')} @font-face{font-family:Roboto;font-style:normal;font-weight:700;src:local('Roboto Bold'),local('Roboto-Bold'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmWUlfChc9.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:900;src:local('Roboto Black'),local('Roboto-Black'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmYUtfChc9.ttf) format('truetype')} </style>
 </head>
<body class="">
<nav class="navbar navbar-custom" role="navigation">
<div class="container-fluid padding-0">
<div class="navbar-header">
<a class="navbar-brand" href="#">
{{ keyword }}
</a>
</div>
<div class="collapse navbar-collapse" id="custom-collapse">
<ul class="nav navbar-nav navbar-right" id="menu-menu-principale"><li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-169" id="menu-item-169"><a href="#">About</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-121" id="menu-item-121"><a href="#">Location</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-120" id="menu-item-120"><a href="#">Menu</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-119" id="menu-item-119"><a href="#">FAQ</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-122" id="menu-item-122"><a href="#">Contacts</a></li>
</ul> </div>
</div>
</nav>
<div class="clearfix"></div>
{{ text }}
<br>
{{ links }}
<footer class="site-footer">
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="site-info">
<p>{{ keyword }} 2021</p></div>
</div>
</div>
</div>
</footer>
</body>
</html>";s:4:"text";s:6623:"Valneva Covid vaccine trials set for Blackpool Victoria Hospital over May bank holiday Blackpool Gazette 04:44 Derriford Hospital Valneva Covid. So far, the UK has secured access to 100 million Oxford-AstraZeneca doses, 40 million Pfizer jab doses, and 17 million doses of the Moderna vaccine, in addition to the 60 million doses from Valneva. ... Clinical trials begin for Valneva Covid vaccine. But it has caught the eye of governments in the UK, Europe, and Australia. 15 Vaccines Approved by at Least One Country. | AFP-JIJI Vaccines have been the success story of the COVID-19 pandemic, with three already approved for use in the UK, and promising late-stage trial results for a further two vaccines backed by the UK government. France's Valneva is in talks with the European Union about supplying the bloc with its possible COVID-19 vaccine, Chief Executive Thomas Lingelbach said on Monday after striking a deal with Britain. Efficacy: Johnson and Johnson said it prevents, on average, 66 per cent of all coronavirus cases among people who get the jab. And vaccines Minister Nadhim Zahawi said the vaccine could also help with the global fight against Covid-19. As the COVID-19 pandemic rapidly spread across the globe earlier this year, along with the worldwide healthcare community, Sanofi considered a range of options to attack COVID-19, initiating tests on existing treatments, while its vaccines unit, Sanofi Pasteur, began studying the new virus and forging strategic partnerships to pool science, expertise and resources. The specialist vaccine company Valneva has announced promising results for the first of two parts of its phase 1/2 trial of a COVID-19 vaccine, with two injections of the highest dose generating levels of virus-neutralizing antibodies higher than those seen in patients recovering from COVID … Tests on a new COVID vaccine in the UK have so far shown it produces a "strong immune response", Health Secretary Matt Hancock has said. 22-04-2021. French-Austrian biotech firm Valneva said Wednesday it will begin clinical trials of its COVID-19 vaccine candidate in Britain, where the government has already ordered at … Team Las Vegas News 1 hour ago. On April 21, Valneva announced the launch of a Phase III clinical study, the last step before a marketing application, for its candidate vaccine against COVID-19. These tests will show whether the vaccine produces a safe and effective immune response against COVID-19. These tests will show whether the vaccine produces a safe and effective immune response against Covid-19. Last Updated 19 May 2021. Valneva is developing a COVID-19 vaccine, which according to its CEO, is the only inactivated COVID-19 vaccine in Europe undergoing clinical development. If successful, larger tests will be planned for April 2021, with more than 4000 UK volunteers taking two doses. Up to 200 volunteers are being recruited for a new Covid-19 vaccine which is the first of its kind. Developed by the specialty vaccine company Valneva, the vaccine is being manufactured at the company’s site in Livingston, West Lothian, and is the only inactivated, adjuvanted (an ingredient to create a stronger immune response) COVID-19 vaccine in clinical development in Europe. The Valneva vaccine is the only whole virus, inactivated and adjuvanted vaccine candidate in clinical trials in Europe. But it has caught the eye of governments in the UK, Europe and Australia. Efficacy: Johnson and Johnson said it prevents, on average, 66 per cent of all coronavirus cases among people who get the jab. Table: “The vaccines in the joint European procurement (the ones that Estonia has already joined are bolded)” The Valneva COVID-19 vaccine is said to be reliant in terms of its reliance against the virus. A COVID-19 vaccine from French company Valneva has yet to complete clinical trials. Article Valneva COVID-19 vaccine begins manufacturing at Scotland plant. If Valneva's vaccine produces as many neutralizing antibodies as AstraZeneca's, it should theoretically protect against Covid. Type: The jab uses the same adenovirus technology as the Oxford University vaccine, making it just as easy to transport and store, but requires just a single injection to protect against Covid. A COVID-19 vaccine from French company Valneva has yet to complete clinical trials. The Valneva vaccine is an inactivated vaccine similar to the Chinese companies Sinovac and Sinopharm, and India’s Bharat Biotech, which have all been approved for emergency use in their countries. As the world awaits pivotal US data on Novavax’s Covid-19 jab, plenty of other players are still trying to get in on the second wave of vaccines. The Pfizer-BioNTech jab got the UK's COVID-19 vaccine programme off to a start on 8 December after being given emergency approval by the Medicines and Healthcare products Regulatory Agency (MHRA) less than a week before. Efficacy: Johnson and Johnson said it prevents, on average, 66 per cent of all coronavirus cases among people who get the jab. Type: The jab uses the same adenovirus technology as the Oxford University vaccine, making it just as easy to transport and store, but requires just a single injection to protect against Covid. Team Las Vegas News 1 hour ago. PA. Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Vaccines in clinical trials include the Valneva COVID-19 vaccine. An adjuvant is an ingredient that helps to create a stronger immune response. Anhui Zhifei Longcom RBD-Dimer. t. e. VLA2001, also known as the Valneva COVID-19 vaccine, is a COVID-19 vaccine candidate developed by French biotechnology company Valneva SE in collaboration with American company Dynavax Technologies. It is a protein subunit vaccine that contains the spike protein of the COVID virus. The vaccine, to be produced in Scotland, is quite different from the currently-available vaccines. A patient receiving the Pfizer vaccine (Image: PA) Type: mRNA . Valneva USA, Inc. is focused on the marketing and distribution of Valneva’s Japanese encephalitis vaccine, IXIARO ®, in the US. Vaccines in clinical trials include the Valneva COVID-19 vaccine. Vaccine name and type? It is an inactivated whole virus vaccine, grown in culture using the Vero cell line. In early July, a British newspaper suggested that Sanofi and GlaxoSmithKline were edging closer to a $625M pact with the U.K. to supply up to 60 million COVID-19 vaccine … A COVID-19 vaccine from French company Valneva has yet to complete clinical trials. ";s:7:"keyword";s:26:"valneva covid vaccine type";s:5:"links";s:612:"<a href="http://digiprint.coding.al/site/tnuujq/declaration-of-conformity-meaning">Declaration Of Conformity Meaning</a>,
<a href="http://digiprint.coding.al/site/tnuujq/trump-international-hotel-las-vegas-parking">Trump International Hotel Las Vegas Parking</a>,
<a href="http://digiprint.coding.al/site/tnuujq/maple-syrup-candy-snow">Maple Syrup Candy Snow</a>,
<a href="http://digiprint.coding.al/site/tnuujq/the-left-to-right-axis-tells-the-performer-what">The Left To Right Axis Tells The Performer What</a>,
<a href="http://digiprint.coding.al/site/tnuujq/babylon-health-rwanda">Babylon Health Rwanda</a>,
";s:7:"expired";i:-1;}

Zerion Mini Shell 1.0